Skip to main content

Blog

A successful symposium - thank you for coming!

Last week we hosted the OpenSAFELY Community Symposium in London - and it was a fantastic success.

Collaborate with us to advance pregnancy and maternity research in OpenSAFELY

We’re starting a new project to prepare maternity data for use in OpenSAFELY, and we’re keen to find collaborators to work with.

Investigating weight gain and obesity with OpenSAFELY

How a team used OpenSAFELY to investigate how the COVID-19 pandemic impacted patterns of weight gain

Help us improve research into COVID-19 Vaccination

Could you help us to improve the research that we are doing into COVID-19 vaccination?

ECHO – A new OpenSAFELY study on COVID-19 vaccines

We’ve launched a new project to understand who received which COVID-19 booster shots, and when, and the impacts of this on health outcomes.

OpenSAFELY Symposium 2024: there's still time to sign up

It’s not too late to register for our OpenSAFELY Symposium, which is happening in London on 25/26 November.

Exciting new developments with hospital medicines data

We briefly summarise all the recent big and exciting developments in hospital medicines data.

OpenSAFELY for retail data? Every little helps

Someone on the radio was musing about using retail data for health - we have some thoughts on that.

Recent paper outputs from the OpenSAFELY Community

In the past 6 months we’ve been very productive at OpenSAFELY publishing 21 peer-reviewed papers on a variety of topics.

The safety of antivirals and neutralising monoclonal antibodies used in prehospital treatment of Covid-19

In this guest blog, Katie Bechman describes the proof-of-principle pharmacovigilance study she conducted with the help of her team from King’s College London, which used OpenSAFELY to examine the safety of sotrovimab, paxlovid and molnupiravir in prehospital treatment of Covid-19.

View more blog posts →